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Osteopathia striata with cranial sclerosis (OS-CS) or Horan-Beighton syndrome is a rare X-linked dominant inherited
bone dysplasia, characterized by longitudinal striations of long bones and cranial sclerosis. Patients can be
asymptomatic or present with typical facial dysmorphism, sensory defects, internal organs anomalies, growth and
mental retardation, depending on the severity of the disease. WTX gene (Xq11) has been recently identified as the
disease causing gene. Aim of this article is to present the case of a 6 year old girl initially evaluated for bilateral
hearing loss. Patient’s head CT scan pointed out sclerosis of skull base and mastoid cells, and abnormal middle-ear
ossification. Clinical examination of the patient and her mother were suspicious for OS-CS. The diagnosis was
confirmed by X-rays examination showing typical longitudinal striation. Genetic analysis allowed the identification
of maternally transmitted heterozygous nonsense c.1057C>T (p.R353X) WTX gene mutation. We also provide a
systematic review of currently available knowledge about clinical, radiologic and genetic features typical of the
OS-CS.
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Osteopathia striata with cranial sclerosis (OS-CS;
OMIM#300373) is a rare, X-linked dominant inherited
skeletal dysplasia (prevalence 0.1/1 million people [1]),
part of sclerosing bone dysplasias [2-4], a group of disor-
ders characterized by abnormally dense bones as a result
of the prevalence of bone formation by osteoblasts over
bone reabsorption by osteoclasts. Striated methaphyses
were firstly described by Voorhoeve in 1924 [5]; thirty
years later, Hurt [3] reported a case of association with
cranial sclerosis. To date, about one hundred cases have
been reported. Age at diagnosis and clinical presentation
is highly variable, ranging from asymptomatic to neo-
natal lethal cases. Skull thickening, responsible for char-
acteristic facies, and linear striations in the metaphyseal* Correspondence: annamaria.zicari@uniroma1.it
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reproduction in any medium, provided the orregion of the long bones and pelvis represent disease
main features, the latter representing a key feature for
differential diagnosis [2-4]. Nervous and internal organs
defects can be associated. Causing-disease mutations of
WTX (Wilms Tumor in the X; also called FAM123B and
AMER1) have recently been identified.
Aim of this paper is to present the first case of OS-CS
with maternal transmission of a heterozygous 1057C>T
WTX gene mutation, and to summarize currently avail-
able knowledge on OS-CS clinical, radiological and
genetic features.
Case report
The proband came to our attention at age 6 for evalu-
ation of recurrent otitis media and bilateral hearing loss
[6]. She was born at the 40th week of gestation after
spontaneous vaginal delivery from unrelated, apparently
healthy parents. Her weight at birth was 3.9 kg (>97th
centile); no facial anomalies were noted. Her mother hadtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Picture of the patient at age 2 (a) showing the typical
narrow forehead with frontal bossing, hypertelorism with
epicanthal folds, up-slanting palpebral fissures, wide depressed
nasal bridge, mid macrocephaly. Picture of the patient’s mother at
age 3 (b) showing mild hypertelorism with epicanthal folds and a
slightly depressed nasal bridge.
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ter (Figure 1). A skull X-ray, performed at age 3 because
of high fever, right-eye and nasal bridge swelling, had
shown dense basilar bones and decreased pneumatiza-
tion of the mastoid and ethmoid cells [6]. Physical exam-
ination performed at age 6 showed narrow forehead
with frontal bossing, hypertelorism with epicanthal folds,
up-slanting palpebral fissures, wide depressed nasal
bridge, mild macrocephaly (head circumference 53.8 cm,
slightly >2SD), hypoplastic maxillae and delayed denti-
tion, low-set ears (Figure 2a), and pectus excavatum.
Inspection of the oral cavity revealed a high-arched pal-
ate and dental-position abnormalities. Otologic examin-
ation showed bilateral mild retraction of the tympanic
membrane. The audiometric test revealed a severe
mixed hearing loss with a wide gap in air conduction on
the left side and medium-grade sensor neural hearing
loss on the right side. High-resolution computed tomog-
raphy (CT) of the temporal bone showed bilateral thick-
ening and bone sclerosis of the skull base and mastoid
cells with narrowing of the middle ear cavity, mastoid
antrum, and eustachian canal, bilateral abnormal ossicu-
lar fixation to the bone surface of the middle ear cavity,
and the presence of phlogistic tissue in the middle ear,
confirmed by magnetic resonance [6]. X-rays of the skull
and legs were performed because of clinical and CT find-
ings suspicious for OS-CS, and revealed cranial vault’s
sclerosis (more pronounced in frontal and parietal bones,
and involving the orbits, sphenoid and petrous bones),
and linear striations in the pelvis and metaphyseal region
of long bones of lower and upper limbs (Figure 3a).
Neurological examination excluded cranial nerves’ dys-
function and psychomotor delay. Cardiovascular and
gastroenterological examinations were also normal.
Patient’s mother presented very similar facial features;
particularly, she had mild hypertelorism with epicanthal
folds, a slightly depressed nasal bridge and hypoplastic
maxillae (Figure 2b). X-rays examination of lower limbsFigure 1 Family tree showing the affected patient (II.4; black
arrow) and her affected mother (I.2), the two male aborted
fetuses (II.1, II.2) and healthy sister (II.3).revealed longitudinal sclerotic striations in the metaphy-
sis of femurs and tibias.
Molecular analysis of WTX
The DNA from peripheral blood leukocytes of the pa-
tient and of her mother was extracted using QIAamp
DNA Blood Mini kit (QIAGEN, Milan, Italy). Sequen-
cing of the entire coding region of WTX was performed
as previously described [7] and allowed the identification
of the heterozygous nonsense mutation c.1057C>T,
leading to a truncated protein (p.R353X) (Figure 3b).
This mutation had been previously reported as a de novo
mutation only in two sporadic cases [8].
Literature review
A systematic literature review was performed using
PubMed database entering the words “osteopathia stri-
ata”, “cranial sclerosis”, “Horan-Beighton syndrome”,
“WTX gene”. Articles written in English and published
since 1953 were included (Additional file 1).
Clinical and radiological features
(Additional file 1)
The clinical presentation is highly variable even within
the same family. Patients can be asymptomatic and acci-
dentally diagnosed during X-rays examinations, or
present with disabling physical anomalies, sometimes
leading to premature death. Age at diagnosis varies from
neonatal period to the 5th decade [9].
Craniofacial dysmorphism
Skull thickening (cranial sclerosis) is the most typical
and early feature [1,6,8,10-37] (85%), often presenting
before longitudinal bone striations, and typically affects
cranial vault, base and some facial bones, leading to sinuses
obliteration and reduction of mastoid pneumatization
[1,10,12-14,19,21,26,33,34] (sometimes responsible for
Figure 3 X-ray of the patient’s femur showing OS-CS typical bone longitudinal striations (a). Sequence analysis of WTX gene performed
on peripheral blood leukocytes in the patient (panel A) and her mother (panel B) showing the heterozygous nonsense mutation 1057C>T
(arrows) (b).
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aly (43%) [2,11-17,19,20,27-32,34,36-39], frontal and
occipital bossing (32%) [2,11-15,17,19-21,30-33,36], man-
dible overgrowth with protuberance of the jaw and dental
malocclusion (12%) [2,11,14,23] (giving a leonine appear-
ance), ocular hypertelorism [6,8,10,14,19,20,23,27,29-31,38-
40], down-slanting palpebral fissures [19,28,31], low set
broad nasal bridge (29%) [1,2,6,8,12,14,15,17,18,20,23,30-
32,37,38,41,42], narrow high-arched or cleft palate (Pierre
Robin’s triad) (12%) [2,6,8,14-16,19,21,30,31,35] and low set
dysplastic ears (9%) [6,12,19,20,29-31,33,39,42].
Skeletal defects
Longitudinal striations can be typically demonstrated in
long bones (73%), less frequently in pelvis (fan-like stria-
tions) (19%)[1,2,6,8,10-15,17-22,24-26,28-32,34-38,40,42],
vertebrae and ribs, and can be associated to diffuse
osteosclerosis (35%) [3,21,25,26,28-32,34,36,43]. Patients
can also present thoracic and vertebral anomalies (2%)
[8,13,14,19-21,28-32,35,42], digital flection contractures,
phalangeal duplication, syndactyly, short or absent fibula,
club feet (3%) [8,10,14,16,17,20,28-31,35,36,38,40].
Neurological manifestations
Hearing loss (conductive or mixed type) is the most com-
mon neurological manifestation (46%) [1,2,6,8,11,14,16,17,
19-23,27,28,30,31,33-38,40,41,43], resulting from narrow-
ing of external auditory canal, impaired mobility of middle
ear ossicles, damage to the inner ear or auditory nerve
entrapment. Narrowed nerves’ canals and foramina are
responsible for nerve encroachment and palsies [1,14,17,
19,20,30,31,37-39,41,42]. A minority of patients presents
intellectual impairment associated to defects of the central
nervous system (i.e. ventricular dilatation, abnormal gyr-
ation, agenesis of corpus callosum) and developmental
delay (overall, 20%) [2,8,14,17,19,20,29-33,35,37-40,43].
Internal organs defects
Patients can finally present congenital heart defects (i.e.
patent ductus arteriosus, atrial and ventricular septaldefects, valvular and conductive defects) (11%) [8,11,12,
14,20,27,29-31,35,37,41,43], respiratory (i.e. laryngotra-
cheomalacia, respiratory distress, nasal obstruction, recur-
rent bronchitis) (13.5%) [6,13,17,19-21,23,28,30,31,37-39],
gastrointestinal (i.e. malrotation, omphalocele, Hirsch-
sprung disease, imperforate anus) (12%) [8,12,13,21,23,29-
32,35] and urogenital (i.e. cryptorchidism, micropenis,
duplicated ureter) (10%) [8,20,29-31,44] anomalies.
OS-CS genetics and genetic-phenotype
correlations
OS-CS has been classically considered an autosomal
dominant condition with high penetrance and variable
intra- and interfamilial expressivity [4,9,12,15-17,21,43]
until the recent identification of mutated WTX (Wilms
Tumor in the X; also called FAM123B and AMER1)
within proximal Xq11.2 in affected families [8]. WTX
can be spliced: the full length form encodes for a 1135
aminoacid protein, WTXs1, which possesses three
binding sites for APC (adenomatous polyposis coli), a
β-catenin- (C-terminal), a WT1- and a PIP2 (phosphati-
dylinositol 4.5 bisphosphate, at N-terminus)- binding
site; and a shorter isoform, WTXs2 (missing aminoacids
50-326) keeps the first APC- binding domain [45-47].
WTX interacts with AXIN1, APC and β-TrCP2, pro-
moting the ubiquitination and proteasomal degradation
of β-catenin (binding site located at the C-terminal) [48]
and the inhibition of the WNT signaling pathway [45].
Both isoforms can bind β-catenin but, while WTXs1 has
a predominant plasma membrane and cytoplasmic
localization, WTXs2 (missing PIP2-binding site) is
retained in the nucleus, suggesting the importance of
cellular localization for protein function [8,45,47]. In
absence of WTX, β-catenin accumulates in the nucleus
and works as a transcriptional co-activator [31]. Because
WNT signal pathway is involved in various embryonic
development (including commitment of mesenchymal
progenitor cells and differentiation of osteoblast precur-
sors [49]) and homeostasis of adult tissues [50], its
enhanced activity, due to mutations of the suppressor
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notypes observed in patients.
Hemizygous males usually are more severely affected
than heterozygous females and present, other than more
marked bone sclerosis, craniofacial abnormalities, gross
structural malformations of bones and internal organs,
and significant pre- and postnatal lethality [20]. More re-
cently, families with mildly affected males, characterized
by longer longevity, mild short stature and neurodeve-
lopmental disability, have been reported [18,26,35,37,43],
although the phenotype has not been completely defined
yet [20]. A genotype-phenotype correlation, where patient
with 5′ WTX mutations were more severely affected than
patients with 3′ WTX mutations was proposed by Jenkins
[8], but not confirmed by Perdu [30,31] who described
mildly affected patients with 5′ WTX mutation, indi-
cating a variable correlation between position of muta-
tion and the severity of the phenotype. Because 5′
mutations produce a truncated, non-functioning protein,
mild phenotype could be the result of a compensatory
activity of WTXs2, even if the exact molecular mechan-
isms remain unidentified [20,46].
Metaphyseal striations can be seen only in females, and
males with mosaic mutations [18,37,40]. A reasonable
explanation is the differential lionization of osteoblasts
for which, similarly to what happens in heterozygous
females presenting with random X chromosome inactiva-
tion patterns, only a certain amount of osteoblasts is
affected [33].
Somatic mutations and deletions of WTX have been
reported in 6 to 30% of patients with Wilms tumors
(WT), a kidney cancer typical of childhood, arising from
multipotent mesenchymal kidney precursors [7,44,46,49];
WTX has later been identified as OS-CS disease-causing-
gene, both in familial and sporadic cases. Despite germline
mutations in tumor suppressor gene confer an elevated
risk for cancer, and patients with WT and OS-CS share a
similar distribution of WTX mutations, OS-CS is not
associated with an increased neoplastic risk [51]. Moisan
et al. [49] demonstrated in a conditional Wtx knockout
mouse model the presence of malformations affecting
organs derived from mesenchymal progenitors, including
kidneys, adipose tissue, heart, spleen and bones, very simi-
lar to those reported in children with OS-CS. At the same
time, some mice developed bilateral multifocal expansion
of renal precursors, but not Wilms tumors, suggesting a
complex role of WTX in kidney development, whose
alteration can lead to tissue agenesis or overgrowth. Muta-
tions associated to WTX-interacting proteins have also
been advocated to explain tumor development [8].
Discussion and conclusions
OS-CS is a rare bone dysplasia, characterized by longitu-
dinal long bone striations and cranial sclerosis. Typicalfacial dysmorphism, sensory defects, internal organs
anomalies, growth and mental retardation can be asso-
ciated, helping the physician in the diagnosis, otherwise
very challenging in asymptomatic cases. Although rare,
because of the severe health impairment that the asso-
ciated malformations could lead to, and the family inher-
itance of the disease, OS-CS should be considered in
patients affected by or with a family history of deafness,
especially if it is associated to facial dysmorphism, sen-
sory defects, internal organ malformations or develop-
mental delay. When OS-CS is suspected, radiographic
imaging such as x-rays of the skull and long bones and
cranial CT, are required to confirm the presence of the
typical bone lesions. Opthalmological examination can
be useful to identify optic nerve defects, as for abdom-
inal and heart ultrasound for the detection of internal
organs malformations, respectively. Family members
should also be investigated. Genetic analyses for WTX
mutations in the patient and in the patient’s family could
be useful for genetic counseling, even if it should be kept
in mind that no clear correlation between genotype and
phenotype exists.
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